Diligence memo · auto-generated · as of July 2, 2026
Malstrom Molecules LLC
Malstrom Molecules LLC looks under-valued against its niche peers and is at-risk on financing cadence.
Businessfiled
Malstrom Molecules LLC operates in Other, based in CAMBRIDGE.
Sector still resolves to a broad 'Other' bucket, so operating comparables below are weaker than for a tightly-classified peer.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Malstrom Molecules LLC has raised $5.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $5.0M on 2024-04-23.
Most recent recorded round closed around 2024-04-23.
Valuation (modeled)modeled
Provath models Malstrom Molecules LLC at approximately $24M (range $6.8M–$54M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.62× the median modeled value of Series A Other companies in 2022–2024 (1135 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 2.2 yr ago; this sector typically re-raises about every 11 months.
Past due for a raise versus sector cadence — watch for distress or a bridge.
Comparablesmixed
Capital scale ranks ahead of 67% of Other peers (25015 compared).
Modeled value ranks above 58% of those peers.
Closest niche peers: Ness Well, Inc., Quantori, Inc., Qquv Investments 5, Llc, Applause Network TV, Inc., Trustworthy Co.
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
Overdue for a raise versus sector norm — distress or bridge risk.
Broad sector classification weakens peer comparison.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.